Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-18-033385
Filing Date
2018-07-24
Accepted
2018-07-24 21:32:35
Documents
2
Period of Report
2018-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2325
2 EXHIBIT 24 ex24.htm EX-24 11515
  Complete submission text file 0001140361-18-033385.txt   15222
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Maxwell John T. (Reporting) CIK: 0001739025 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 18967488